Limited ability to activate protein C confers left atrial endocardium a thrombogenic phenotype: A role in cardioembolic stroke?

Stroke

Volumn 42, Issue 9, 2011, Pages 2622-2624

  Cerveró, Jorge ^a   Montes, Ramón ^a   España, Francisco ^b   Esmon, Charles T ^c   Hermida, José ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

anticoagulation; embolic stroke; embolism; endothelium; protein C anticoagulant system; thrombomodulin

Indexed keywords

ACTIVATED PROTEIN C RECEPTOR; ENDOTHELIAL PROTEIN C RECEPTOR; PROTEIN C; THROMBOMODULIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN EMBOLISM; CARDIOEMBOLIC STROKE; CONTROLLED STUDY; ENDOCARDIUM; ENZYME ACTIVATION; HEART LEFT ATRIUM; HEART RIGHT ATRIUM; IMMUNOFLUORESCENCE TEST; MACACA FASCICULARIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROKE; THROMBOGENICITY;

ANIMALS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; BLOOD COAGULATION FACTORS; ENDOCARDIUM; ENDOTHELIUM; GENE EXPRESSION REGULATION; MACACA FASCICULARIS; PHENOTYPE; PROTEIN C; RECEPTORS, CELL SURFACE; STROKE; THROMBOMODULIN; THROMBOSIS;

EID: 80052415539     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.614420     Document Type: Article

References (15)

1. Lip GY, Tse HF. Management of atrial fibrillation. Lancet. 2007;370: 604-618.
2. Thambidorai SK, Murray RD, Parakh K, Shah TK, Black IW, Jasper SE, et al. Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol. 2005;96:935-941.
3. de Divitiis M, Omran H, Rabahieh R, Rang B, Illien S, Schimpf R, et al. Right atrial appendage thrombosis in atrial fibrillation: its frequency and its clinical predictors. Am J Cardiol. 1999;84:1023-1028.
4. Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res. 2007;100:174-190.
5. Esmon CT, Gu JM, Xu J, Qu D, Stearns-Kurosawa DJ, Kurosawa S. Regulation and functions of the protein C anticoagulant pathway. Haematologica. 1999;84:363-368.
6. Laszik Z, Mitro A, Taylor FB Jr, Ferrell G, Esmon CT. Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation. 1997; 96:3633-3640.
7. Ishii H, Salem HH, Bell CE, Laposata EA, Majerus PW. Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain. Blood. 1986;67:362-365.
8. Brooks EG, Trotman W, Wadsworth MP, Taatjes DJ, Evans MF, Ittleman FP, et al. Valves of the deep venous system: an overlooked risk factor. Blood. 2009;114:1276-1279.
9. Koster T, Rosendaal FR, Briët E, van der Meer FJ, Colly LP, Trienekens PH, et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood. 1995;85:2756-2761.
10. Hurtado V, Montes R, Gris JC, Bertolaccini ML, Alonso A, Martínez-González MA, et al. Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death. Blood. 2004;104: 1369-1374.
11. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood. 2007;109:3161-3172.
12. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006;27:136-149.
13. España F, Vayá A, Mira Y, Medina P, Estellés A, Villa P, et al. Low level of circulating activated protein C is a risk factor for venous thromboembolism. Thromb Haemost. 2001;86:1368-1373.
14. Folsom AR, Ohira T, Yamagishi K, Cushman M. Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. J Thromb Haemost. 2009;7: 1774-1778.
15. Taylor FB Jr, Peer GT, Lockhart MS, Ferrell G, Esmon CT. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood. 2001;97:1685-1688.